EnteroMedics announces pricing of $20 million underwritten public offering
EnteroMedics announced pricing of an underwritten public offering of units for gross proceeds of $20 million. The offering consists of units, priced at $1,000 per unit, comprised of one share of series B convertible preferred stock convertible into 435 shares of common stock. August 11, 2017